We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Palisade Bio Inc | NASDAQ:PALI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.04 | 0.86% | 4.68 | 4.46 | 4.78 | 4.6344 | 4.46 | 4.55 | 6,864 | 01:00:00 |
As part of the event, J.D. Finley, Chief Executive Officer and Dr. Mitch Jones, Chief Medical Officer of Palisade Bio, will provide a corporate overview, business outlook, and discuss the Palisade Bio opportunity.
A live video webcast of the presentation will be available on the Events page of the Investors section of the Company’s website (www.palisadebio.com). A webcast replay will be available two hours following the live presentation and will be accessible for 90 days.
About Palisade Bio Palisade Bio is a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The Company believes that by using a targeted approach with its novel therapeutics it will transform the treatment landscape. For more information, please go to www.palisadebio.com.
Investor Relations ContactJTC Team, LLCJenene Thomas 833-475-8247PALI@jtcir.com
1 Year Palisade Bio Chart |
1 Month Palisade Bio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions